Items where authors include "Porter, C."

Article

Fennell, D.A. orcid.org/0000-0001-7373-1312, Porter, C., Lester, J. et al. (8 more authors) (2022) Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): a multicentre, randomised, controlled, phase 2 trial. eClinicalMedicine, 52. 101595. ISSN 2589-5370

Fennell, D.A. orcid.org/0000-0001-7373-1312, Porter, C., Lester, J. et al. (14 more authors) (2022) Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. eClinicalMedicine, 48. 101432. ISSN 2589-5370

Prout, H.C. orcid.org/0000-0003-0170-7027, Barham, A., Bongard, E. et al. (15 more authors) (2018) Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials, 19. 419.

Neal, R.D., Barham, A., Bongard, E. et al. (15 more authors) (2017) Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. British Journal of Cancer, 116. pp. 293-302. ISSN 0007-0920

Wilcox, M.H., Fitzgerald, P., Freeman, J. et al. (7 more authors) (2000) A five year outbreak of methicillin-susceptible Staphylococcus aureus phage type 53,85 in a regional neonatal unit. Epidemiology and Infection, 124 (1). pp. 37-45. ISSN 0950-2688

Proceedings Paper

Wanat, M. orcid.org/0000-0002-0163-1547, Anthierens, S. orcid.org/0000-0003-4762-1907, Santillo, M. et al. (14 more authors) (2023) Managing Penicillin Allergy in Primary Care: An Important but Neglected Aspect of Antibiotic Stewardship. In: Medical Sciences Forum. ESPAUR Webinar and Report 2021–2022, 23 Nov 2022, Online. MDPI .